REGISTRY on the Implementation of Artificial Intelligence in the Automatic Analysis of Vascular Network Segmentation

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

The team hypothesizes that fully automatic analysis of AAA could provide increased performance (decreased duration of segmentation with increased reproducibility and decreased inter and intraobserver variability) to detect aortic aneurysmal sac enlargement (volumes and diameters) and predict the risk of complications during the procedure and during follow-up (MAE, MACE, MALE, Stroke) compared to standard methods of measurement relying on approximate maximum sac diameter.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Male or female ≥18 years of age

• AAA treated with EVAR between

‣ ≥50mm

⁃ or ≥5mm increase in 6 months

• The subject is legally competent, has been informed of the nature, the scope, and the relevance of the study and has not manifested an opposition to participate.

• Available for set-up and proper implementation of follow-up visits (standard of care) throughout the duration of the registry

Locations
Other Locations
France
Service de Chirurgie Vasculaire, Hôpital Pellegrin-tripode, CHU de Bordeaux
RECRUITING
Bordeaux
Contact Information
Primary
Eric DUCASSE, MD, PhD
eric.ducasse@chu-bordeaux.fr
+33 5 56 79 55 25
Backup
Olivier DELORME
olivier.delorme@chu-bordeaux.fr
+ 33 5 57 65 60 05
Time Frame
Start Date: 2024-01-30
Estimated Completion Date: 2024-07-15
Participants
Target number of participants: 250
Treatments
Abdominal Aortic Aneurysm (AAA) treated with EndoVascular Aneurysm Repair (EVAR)
Male or female ≥18 years of age with AAA treated with EVAR between ≥50mm or ≥5mm increase in 6 months. The subject is legally competent, has been informed of the nature, the scope, and the relevance of the study and has not manifested an opposition to participate. He is available for set-up and proper implementation of follow-up visits (standard of care) throughout the duration of the registry
Sponsors
Collaborators: Nurea
Leads: University Hospital, Bordeaux

This content was sourced from clinicaltrials.gov